• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
KPR
Click for more information
0.00% 4.0¢

KUPANG RESOURCES LTD

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
KPR
simon youds latest video on kpr 		16/11/16 14 6.9K
16/11/16 Last post  The Mole Comments Created with Sketch.  14  Views Created with Sketch.  6.9K 
KPR
Ann: DKPM Recommends Permits for Export 		04/11/16 13 6.8K
04/11/16 Last post  The Mole Comments Created with Sketch.  13  Views Created with Sketch.  6.8K 
KPR
Ann: Domestic Sales of Manganese Targeted for March/April 2015 		04/11/16 5 2.8K
Healthcare SECTOR NEWS

Recce targets Indonesia for its innovative anti-infective as Indo-Aussie ties strengthen!

Read More   right-arrow Created with Sketch.
RCE
02 Oct 2024
RECCE PHARMACEUTICALS LTD
04/11/16 Last post  The Mole Comments Created with Sketch.  5  Views Created with Sketch.  2.8K 
KPR
exempt from progressive tax? 		04/11/16 2 1.5K
04/11/16 Last post  The Mole Comments Created with Sketch.  2  Views Created with Sketch.  1.5K 
KPR
Administrator's Report 		18:22 2 1.6K
18:22 Last post  The Mole Comments Created with Sketch.  2  Views Created with Sketch.  1.6K 
KPR
Ann: Suspension from Official Quotation - Annual Listing Fees 		08/08/16 2 1.9K
08/08/16 Last post  Muza Comments Created with Sketch.  2  Views Created with Sketch.  1.9K 
KPR
Ann: Removal from Official List 		31/08/15 0 1.0K
31/08/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  1.0K 
KPR
Ann: Letter to Shareholders 		28/08/15 0 1.3K
28/08/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  1.3K 

See All Discussions arrow Created with Sketch.

Featured News

RCE Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger
right-arrow Created with Sketch.
NEWS Shallow high-grade gold hits at Star of Mangaroon and Popeye—see the latest drill results and what’s next
right-arrow Created with Sketch.
NEWS Exceptional rock chip assays at Pearl Copper Project—up to 930 g/t Ag and 10.05% Cu in Arizona
right-arrow Created with Sketch.
NEWS Significant copper and TREO results from West Arunta Project indicate a substantial multi-million tonne copper resource, with mineralisation starting from surface
right-arrow Created with Sketch.
NEWS Major shallow copper-silver discovery at Junction Prospect confirmed with high-grade intercepts
right-arrow Created with Sketch.
NEWS Solar building envelope order secured for iconic WA project—discover more about this groundbreaking solar solution
right-arrow Created with Sketch.

Top Stories

ASX Market Open: Modest gains factored in as Middle East drama persists | Thurs 3rd Oct

Good morning and a happy Thursday. The ASX200 is tipped to post modest gains of +0.16% on Thursday per futures at 8.30am Sydney time.
Macmahon wins $61M from Rinehart's HanRoy for Marble Bar Road upgrade, WA Macmahon (ASX:MAH) has announced it's won a $61M contract from Gina Rinehart's HanRoy to upgrade the WA-based Marble Bar Road.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.

Featured News

NEWS High-grade drilling results extend Cowboy State Mine—172.4m @ 3,716 ppm TREO confirmed
right-arrow Created with Sketch.
NEWS Drilling at May Queen intersects altered porphyritic rocks and copper sulphides, supporting a large-scale copper-gold system
right-arrow Created with Sketch.
NEWS Drilling kicks off at Goldsworthy East—30 holes planned to unlock major westward potential
right-arrow Created with Sketch.
NEWS Major shallow copper-silver discovery at Junction Prospect confirmed with high-grade intercepts
right-arrow Created with Sketch.
NEWS Exceptional rock chip assays at Pearl Copper Project—up to 930 g/t Ag and 10.05% Cu in Arizona
right-arrow Created with Sketch.
NEWS Eagles Nest drilling confirms high-grade gold with shallow mineralisation expanding, delivering multiple strong intersections
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.